Released on = July 25, 2006, 4:21 am

Press Release Author = RNCOS

Industry = Industrial

Press Release Summary = Pharmacogenomics, the science of genetic inheritance of an
individual's response to drugs, is being increasingly applied at the clinical level.
The pharmacogenomics market is expected to reach $4Bn by 2009

Press Release Body = The term 'Pharmacogenomics' is evolved from the words -
pharmacology and genomics and therefore a combination of pharmaceuticals and
genetics. Pharmacogenomics is a specialized study of how the genetic inheritance of
an individual affects his body's response to drugs. Being increasingly applied at
the clinical level, its application is aimed on specific genes for therapeutics, and
on screening genes for potential drug uses. It also aids pharmaceuticals in the
development of highly sophisticated medications.

The application of pharmacogenomics is based on the combination of traditional
pharmaceutical sciences such as biochemistry along with knowledge of genes,
proteins, and single nucleotide polymorphisms. The present Pharmacogenomics market
is comprised of three central segments, which are projected with a high growth rate.
These are SNP identification technologies, genotyping technologies, and diagnostics.

The thrust of pharmacogenomics depends on the genome-wide analysis of the genetic
characteristics of drug toxity and drug efficacy. This is a challenge to the ability
to identify genetic variations also called polymorphisms that change a person's
reaction to a drug.

RNCOS in its market research report, "Bioinformatics Market Update (2006)" presents
a compact analysis with respect to the current market for pharmacogenomics and its
future propensity. Presently there has not been enough penetration in this area,
thus leaving enormous scope for research and growth. This research report on
Bioinformatics industry indicates particular interest in the markets for SNP
Identification technologies, Genotyping technologies, and Diagnostics. Another area
of interest is the market for selected drugs aided by the use of pharmacogenomics.

The report also states that the global bioinformatics market for pharmacogenomics
reached $1.25Bn in 2004 and is estimated to jump to $4Bn by 2009 with an AAGR of
25%.

The report provides answers for some critical questions relating to -
. The current global outlook of Bioinformatics market;
. The recent developments in the Bioinformatics industry;
. The worldwide growth of the Genomics market;
. The driving forces of the Bioinformatics market;
. The opportunities for growth and impending threats for the industry; and
. Comparison between different companies in the Bioinformatics market.

The report is a useful guide for the pharmaceutical companies, IT firms,
biotechnology firms, prospective investors, students and academicians in the field
of bioinformatics.

About RNCOS:
RNCOS, incorporated in 2002, provides Market Research Reports for your business
needs and aims to put an end to your information pursuit. Our expertise in gathering
global business information for industry research, corporate training, growth
consulting, and business consulting, brings reputed companies and firms to us for
business enhancement solutions. We can be your one-stop-shop for Industry research
information and niche market analysis

To purchase your copy: http://www.rncos.com/Report/IM045.htm
For more information about the report please visit www.rncos.com


Web Site = http://www.rncos.com

Contact Details = RNCOS
Shushmul Maheshwari
Head of Business Development
29, 1st Floor, Patparganj Industrial area, Delhi 92
91-11-4214-1229
info@rncos.com